Semnur Pharmaceuticals, Inc. Temporary Equity, Accretion of Interest
Semnur Pharmaceuticals, Inc. (SMNR) reported Temporary Equity, Accretion of Interest of $539.55 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:TemporaryEquityAccretionOfInterest · last filed 2024-05-22
- Semnur Pharmaceuticals, Inc. temporary equity, accretion of interest for the quarter ending 2024-03-31 was $539.55K, a 71.92% decline year-over-year.
- Semnur Pharmaceuticals, Inc. temporary equity, accretion of interest for the quarter ending 2023-03-31 was $1.92M.
- Semnur Pharmaceuticals, Inc. temporary equity, accretion of interest for fiscal 2023 was $5.01M, a 71.77% decline from fiscal 2022.
- Semnur Pharmaceuticals, Inc. temporary equity, accretion of interest for fiscal 2022 was $17.75M.
| Period end | Temporary Equity, Accretion of Interest 3 month | Temporary Equity, Accretion of Interest 12 month |
|---|---|---|
| 2024-03-31 | $539.55K 10-Q · filed 2024-05-22 | |
| 2023-12-31 | $5.01M 10-K · filed 2024-04-01 | |
| 2023-03-31 | $1.92M 10-Q · filed 2024-05-22 | |
| 2022-12-31 | $17.75M 10-K · filed 2024-04-01 |